vs
GAIA, INC(GAIA)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
GAIA, INC的季度营收约是STANDARD BIOTOOLS INC.的1.3倍($25.5M vs $19.6M),GAIA, INC净利率更高(-0.3% vs -177.4%,领先177.1%),GAIA, INC同比增速更快(5.8% vs -11.5%),GAIA, INC自由现金流更多($76.0K vs $-23.1M),过去两年GAIA, INC的营收复合增速更高(9.4% vs -12.2%)
Gaia Inc.是一家美国媒体公司,1988年由伊尔卡·里萨维在科罗拉多州路易斯维尔创立,在纳斯达克上市,股票代码GAIA。该公司运营订阅视频点播平台Gaia TV,提供原创和授权的另类媒体纪录片,内容涵盖健康、灵性等主题。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
GAIA vs LAB — 直观对比
营收规模更大
GAIA
是对方的1.3倍
$19.6M
营收增速更快
GAIA
高出17.3%
-11.5%
净利率更高
GAIA
高出177.1%
-177.4%
自由现金流更多
GAIA
多$23.2M
$-23.1M
两年增速更快
GAIA
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $25.5M | $19.6M |
| 净利润 | $-75.0K | $-34.7M |
| 毛利率 | 87.6% | 48.5% |
| 营业利润率 | -2.6% | -168.5% |
| 净利率 | -0.3% | -177.4% |
| 营收同比 | 5.8% | -11.5% |
| 净利润同比 | 91.7% | -28.8% |
| 每股收益(稀释后) | $-0.02 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GAIA
LAB
| Q4 25 | $25.5M | — | ||
| Q3 25 | $25.0M | $19.6M | ||
| Q2 25 | $24.6M | $21.8M | ||
| Q1 25 | $23.8M | $40.8M | ||
| Q4 24 | $24.1M | — | ||
| Q3 24 | $22.0M | $22.1M | ||
| Q2 24 | $21.9M | $22.5M | ||
| Q1 24 | $21.3M | $45.5M |
净利润
GAIA
LAB
| Q4 25 | $-75.0K | — | ||
| Q3 25 | $-1.2M | $-34.7M | ||
| Q2 25 | $-2.0M | $-33.5M | ||
| Q1 25 | $-1.2M | $-26.0M | ||
| Q4 24 | $-907.0K | — | ||
| Q3 24 | $-1.2M | $-26.9M | ||
| Q2 24 | $-2.2M | $-45.7M | ||
| Q1 24 | $-971.0K | $-32.2M |
毛利率
GAIA
LAB
| Q4 25 | 87.6% | — | ||
| Q3 25 | 86.4% | 48.5% | ||
| Q2 25 | 86.7% | 48.8% | ||
| Q1 25 | 87.7% | 48.4% | ||
| Q4 24 | 88.2% | — | ||
| Q3 24 | 86.1% | 54.9% | ||
| Q2 24 | 84.5% | 46.1% | ||
| Q1 24 | 85.3% | 53.1% |
营业利润率
GAIA
LAB
| Q4 25 | -2.6% | — | ||
| Q3 25 | -5.0% | -168.5% | ||
| Q2 25 | -8.9% | -118.1% | ||
| Q1 25 | -4.3% | -80.8% | ||
| Q4 24 | -7.1% | — | ||
| Q3 24 | -5.3% | -120.9% | ||
| Q2 24 | -9.1% | -134.5% | ||
| Q1 24 | -4.0% | -132.2% |
净利率
GAIA
LAB
| Q4 25 | -0.3% | — | ||
| Q3 25 | -4.6% | -177.4% | ||
| Q2 25 | -8.3% | -153.7% | ||
| Q1 25 | -5.1% | -63.8% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -5.4% | -122.0% | ||
| Q2 24 | -9.9% | -203.3% | ||
| Q1 24 | -4.6% | -70.6% |
每股收益(稀释后)
GAIA
LAB
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $-0.05 | $-0.09 | ||
| Q2 25 | $-0.07 | $-0.09 | ||
| Q1 25 | $-0.04 | $-0.07 | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-0.05 | $-0.07 | ||
| Q2 24 | $-0.09 | $-0.12 | ||
| Q1 24 | $-0.05 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $13.5M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $87.9M | $399.7M |
| 总资产 | $154.6M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
GAIA
LAB
| Q4 25 | $13.5M | — | ||
| Q3 25 | $14.2M | $129.4M | ||
| Q2 25 | $13.9M | $158.6M | ||
| Q1 25 | $13.1M | $150.9M | ||
| Q4 24 | $5.9M | — | ||
| Q3 24 | $4.4M | $210.6M | ||
| Q2 24 | $5.5M | $269.8M | ||
| Q1 24 | $8.6M | $287.1M |
总债务
GAIA
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益
GAIA
LAB
| Q4 25 | $87.9M | — | ||
| Q3 25 | $86.3M | $399.7M | ||
| Q2 25 | $85.7M | $424.5M | ||
| Q1 25 | $87.0M | $454.6M | ||
| Q4 24 | $80.7M | — | ||
| Q3 24 | $81.2M | $489.3M | ||
| Q2 24 | $82.1M | $510.3M | ||
| Q1 24 | $84.8M | $577.3M |
总资产
GAIA
LAB
| Q4 25 | $154.6M | — | ||
| Q3 25 | $151.1M | $539.6M | ||
| Q2 25 | $147.0M | $557.0M | ||
| Q1 25 | $148.5M | $579.6M | ||
| Q4 24 | $141.2M | — | ||
| Q3 24 | $139.6M | $681.5M | ||
| Q2 24 | $142.1M | $708.7M | ||
| Q1 24 | $133.8M | $777.7M |
负债/权益比
GAIA
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.8M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $76.0K | $-23.1M |
| 自由现金流率自由现金流/营收 | 0.3% | -118.1% |
| 资本支出强度资本支出/营收 | 6.6% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-377.0K | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
GAIA
LAB
| Q4 25 | $1.8M | — | ||
| Q3 25 | $326.0K | $-22.2M | ||
| Q2 25 | $2.3M | $-20.7M | ||
| Q1 25 | $1.3M | $-30.3M | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $409.0K | $-27.9M | ||
| Q2 24 | $-2.1M | $-39.0M | ||
| Q1 24 | $5.9M | $-62.5M |
自由现金流
GAIA
LAB
| Q4 25 | $76.0K | — | ||
| Q3 25 | $-1.6M | $-23.1M | ||
| Q2 25 | $880.0K | $-22.6M | ||
| Q1 25 | $268.0K | $-35.3M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $-952.0K | $-30.1M | ||
| Q2 24 | $-3.5M | $-41.0M | ||
| Q1 24 | $4.9M | $-63.3M |
自由现金流率
GAIA
LAB
| Q4 25 | 0.3% | — | ||
| Q3 25 | -6.4% | -118.1% | ||
| Q2 25 | 3.6% | -103.6% | ||
| Q1 25 | 1.1% | -86.6% | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | -4.3% | -136.4% | ||
| Q2 24 | -16.1% | -182.2% | ||
| Q1 24 | 22.8% | -138.9% |
资本支出强度
GAIA
LAB
| Q4 25 | 6.6% | — | ||
| Q3 25 | 7.7% | 4.5% | ||
| Q2 25 | 5.7% | 8.7% | ||
| Q1 25 | 4.3% | 12.4% | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 6.2% | 10.2% | ||
| Q2 24 | 6.6% | 8.6% | ||
| Q1 24 | 5.0% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GAIA
| US | $16.7M | 65% |
| Non Us | $8.8M | 35% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |